NCT02314572

Brief Summary

The objective of this study is to assess the visual outcome after the combined binocular implantation of +2.5 D and +3.0 D apodized diffractive multifocal intraocular lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2013

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 11, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

December 16, 2015

Status Verified

December 1, 2015

Enrollment Period

1.8 years

First QC Date

December 8, 2014

Last Update Submit

December 15, 2015

Conditions

Keywords

Multifocal Intraocular LensBinocular TrifocalityCataract SurgerySpectacle IndependenceIntermediate VisionPhotopic VisionMesopic VisionScotopic VisionBinocular Vision

Outcome Measures

Primary Outcomes (6)

  • Visual acuities in the far, intermediate and near

    Visual acuities are tested under photopic conditions at 5 m, intermediate (80 cm) and patient-preferred near distance (≈ 40 cm).

    1 month

  • Visual acuities in the far, intermediate and near

    Visual acuities are tested under photopic conditions at 5 m, intermediate (80 cm) and patient-preferred near distance (≈ 40 cm).

    3 months

  • Mesopic vision

    Mesopic visual acuities are tested under high-contrast, low-contrast and low-contrast with glare.

    1 month

  • Mesopic vision

    Mesopic visual acuities are tested under high-contrast, low-contrast and low-contrast with glare.

    3 months

  • Scotopic contrast sensitivity

    Scotopic contrast sensitivity are tested at 0.1 cd/m2, 0.032 cd/m2 and 0.1 cd/m2 with glare.

    1 month

  • Scotopic contrast sensitivity

    Scotopic contrast sensitivity are tested at 0.1 cd/m2, 0.032 cd/m2 and 0.1 cd/m2 with glare.

    3 months

Secondary Outcomes (1)

  • Spectacle independence in the far, intermediate and near

    3 months

Study Arms (1)

Single-arm

OTHER
Device: Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses

Interventions

Binocular implantation of the combination of AcrySof® IQ ReSTOR® multifocal intraocular lenses with an addition of +2.5 D in the distance-dominant eye and +3.0 D in the fellow eye.

Also known as: AcrySof® IQ ReSTOR® multifocal intraocular lenses with an addition of +2.5 D (SV25-type) and +3.0 D (SN6A-type) are used.
Single-arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinically significant cataract
  • endothelial cell count: patients aged 18-75 years: \> 1000 cells/mm2; patients \> 75 years: \> 750 cells/mm2
  • absence of vision-limiting corneal or retinal comorbidities
  • capability to understand the informed consent

You may not qualify if:

  • expected postoperative astigmatism \> 0.75 diopters
  • irregular astigmatism
  • dilated pupil diameter \< 3 mm
  • corneal and fundus abnormalities that might cause visual impairments
  • inability to attend follow-up visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - University Medicine Berlin, Department of Ophthalmology

Berlin, State of Berlin, 13353, Germany

Location

Related Publications (6)

  • Pedrotti E, Mastropasqua R, Passilongo M, Parisi G, Marchesoni I, Marchini G. Comparison of two multifocal intraocular lens designs that differ only in near add. J Refract Surg. 2014 Nov;30(11):754-60. doi: 10.3928/1081597X-20141021-07.

    PMID: 25375848BACKGROUND
  • Alfonso JF, Knorz M, Fernandez-Vega L, Rincon JL, Suarez E, Titke C, Kohnen T. Clinical outcomes after bilateral implantation of an apodized +3.0 D toric diffractive multifocal intraocular lens. J Cataract Refract Surg. 2014 Jan;40(1):51-9. doi: 10.1016/j.jcrs.2013.06.026.

    PMID: 24355720BACKGROUND
  • Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation: a multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Ophthalmology. 2000 Nov;107(11):2040-8. doi: 10.1016/s0161-6420(00)00368-7.

    PMID: 11054329BACKGROUND
  • Vingolo EM, Grenga P, Iacobelli L, Grenga R. Visual acuity and contrast sensitivity: AcrySof ReSTOR apodized diffractive versus AcrySof SA60AT monofocal intraocular lenses. J Cataract Refract Surg. 2007 Jul;33(7):1244-7. doi: 10.1016/j.jcrs.2007.03.052.

    PMID: 17586381BACKGROUND
  • Cillino G, Casuccio A, Pasti M, Bono V, Mencucci R, Cillino S. Working-age cataract patients: visual results, reading performance, and quality of life with three diffractive multifocal intraocular lenses. Ophthalmology. 2014 Jan;121(1):34-44. doi: 10.1016/j.ophtha.2013.06.034. Epub 2013 Aug 14.

    PMID: 23953097BACKGROUND
  • Chiam PJ, Chan JH, Aggarwal RK, Kasaby S. ReSTOR intraocular lens implantation in cataract surgery: quality of vision. J Cataract Refract Surg. 2006 Sep;32(9):1459-63. doi: 10.1016/j.jcrs.2006.04.015.

    PMID: 16931256BACKGROUND

MeSH Terms

Conditions

Cataract

Interventions

Phacoemulsification

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Cataract ExtractionRefractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Officials

  • Eckart Bertelmann, MD, PhD

    eckart.bertelmann@charite.de

    PRINCIPAL INVESTIGATOR
  • Tobias Brockmann, MD

    tobias.brockmann@charite.de

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
managing senior physician

Study Record Dates

First Submitted

December 8, 2014

First Posted

December 11, 2014

Study Start

March 1, 2013

Primary Completion

December 1, 2014

Study Completion

June 1, 2015

Last Updated

December 16, 2015

Record last verified: 2015-12

Locations